Prevention and treatment of motor fluctuations

Research output: Contribution to journalArticle

Abstract

The symptoms of Parkinson's disease can become increasingly difficult to control as the disease advances, particularly with the development of motor complications, such as end-of-dose wearing-off and dyskinesias, following long-term therapy. At this stage, the patient is frequently referred to a Parkinson's disease specialist for advice on the management of their disease. In this review we provide an overview of the Parkinson's disease specialist's strategies for coping with such problems. This includes strategy to prevent or delay motor fluctuations and the concept of the long duration response. The paper also includes establishing the optimum and most rational levodopa treatment schedule, improving levodopa absorption, use of COMT-inhibition, the addition of oral dopaminergic agonists, and the use of subcutaneous injections or infusions of apomorphine or lisuride. Finally, we highlight the increasing importance of treatment strategies that stimulate dopamine receptors in a more continuous, less pulsatile manner as a way of reducing the risk of developing treatment-associated motor complications.

Original languageEnglish
JournalParkinsonism and Related Disorders
Volume9
Issue numberSUPPL. 2
DOIs
Publication statusPublished - Aug 2003

Fingerprint

Parkinson Disease
Levodopa
Lisuride
Subcutaneous Infusions
Apomorphine
Dopamine Agonists
Dyskinesias
Dopamine Receptors
Subcutaneous Injections
Therapeutics
Disease Management
Appointments and Schedules

Keywords

  • Advanced Parkinson's disease
  • COMT inhibitors
  • Dopamine agonists
  • Dyskinesias
  • Levodopa

ASJC Scopus subject areas

  • Ageing
  • Clinical Neurology
  • Neurology

Cite this

Prevention and treatment of motor fluctuations. / Stocchi, Fabrizio.

In: Parkinsonism and Related Disorders, Vol. 9, No. SUPPL. 2, 08.2003.

Research output: Contribution to journalArticle

@article{cdc8a52adcec4f719115edf054884623,
title = "Prevention and treatment of motor fluctuations",
abstract = "The symptoms of Parkinson's disease can become increasingly difficult to control as the disease advances, particularly with the development of motor complications, such as end-of-dose wearing-off and dyskinesias, following long-term therapy. At this stage, the patient is frequently referred to a Parkinson's disease specialist for advice on the management of their disease. In this review we provide an overview of the Parkinson's disease specialist's strategies for coping with such problems. This includes strategy to prevent or delay motor fluctuations and the concept of the long duration response. The paper also includes establishing the optimum and most rational levodopa treatment schedule, improving levodopa absorption, use of COMT-inhibition, the addition of oral dopaminergic agonists, and the use of subcutaneous injections or infusions of apomorphine or lisuride. Finally, we highlight the increasing importance of treatment strategies that stimulate dopamine receptors in a more continuous, less pulsatile manner as a way of reducing the risk of developing treatment-associated motor complications.",
keywords = "Advanced Parkinson's disease, COMT inhibitors, Dopamine agonists, Dyskinesias, Levodopa",
author = "Fabrizio Stocchi",
year = "2003",
month = "8",
doi = "10.1016/S1353-8020(03)00021-X",
language = "English",
volume = "9",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Prevention and treatment of motor fluctuations

AU - Stocchi, Fabrizio

PY - 2003/8

Y1 - 2003/8

N2 - The symptoms of Parkinson's disease can become increasingly difficult to control as the disease advances, particularly with the development of motor complications, such as end-of-dose wearing-off and dyskinesias, following long-term therapy. At this stage, the patient is frequently referred to a Parkinson's disease specialist for advice on the management of their disease. In this review we provide an overview of the Parkinson's disease specialist's strategies for coping with such problems. This includes strategy to prevent or delay motor fluctuations and the concept of the long duration response. The paper also includes establishing the optimum and most rational levodopa treatment schedule, improving levodopa absorption, use of COMT-inhibition, the addition of oral dopaminergic agonists, and the use of subcutaneous injections or infusions of apomorphine or lisuride. Finally, we highlight the increasing importance of treatment strategies that stimulate dopamine receptors in a more continuous, less pulsatile manner as a way of reducing the risk of developing treatment-associated motor complications.

AB - The symptoms of Parkinson's disease can become increasingly difficult to control as the disease advances, particularly with the development of motor complications, such as end-of-dose wearing-off and dyskinesias, following long-term therapy. At this stage, the patient is frequently referred to a Parkinson's disease specialist for advice on the management of their disease. In this review we provide an overview of the Parkinson's disease specialist's strategies for coping with such problems. This includes strategy to prevent or delay motor fluctuations and the concept of the long duration response. The paper also includes establishing the optimum and most rational levodopa treatment schedule, improving levodopa absorption, use of COMT-inhibition, the addition of oral dopaminergic agonists, and the use of subcutaneous injections or infusions of apomorphine or lisuride. Finally, we highlight the increasing importance of treatment strategies that stimulate dopamine receptors in a more continuous, less pulsatile manner as a way of reducing the risk of developing treatment-associated motor complications.

KW - Advanced Parkinson's disease

KW - COMT inhibitors

KW - Dopamine agonists

KW - Dyskinesias

KW - Levodopa

UR - http://www.scopus.com/inward/record.url?scp=0041659345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041659345&partnerID=8YFLogxK

U2 - 10.1016/S1353-8020(03)00021-X

DO - 10.1016/S1353-8020(03)00021-X

M3 - Article

C2 - 12915071

AN - SCOPUS:0041659345

VL - 9

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

IS - SUPPL. 2

ER -